Carl Knud Schewe

Summary

Country: Germany

Publications

  1. ncbi request reprint Improved lipid profiles and maintenance of virologic control in heavily pretreated HIV-infected patients who switched from stavudine to tenofovir treatment
    Carl Knud Schewe
    Praxis St Georg, Hamburg, Germany
    Clin Infect Dis 42:145-7. 2006
  2. ncbi request reprint [Management of primary HIV-infection]
    C K Schewe
    Facharzt für Innere Medizin, Praxis St Georg, Hamburg
    MMW Fortschr Med 147:24-6. 2005
  3. ncbi request reprint Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment
    Oliver Schildgen
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitat Bonn, 53105 Bonn, Germany
    AIDS 18:2325-7. 2004

Detail Information

Publications3

  1. ncbi request reprint Improved lipid profiles and maintenance of virologic control in heavily pretreated HIV-infected patients who switched from stavudine to tenofovir treatment
    Carl Knud Schewe
    Praxis St Georg, Hamburg, Germany
    Clin Infect Dis 42:145-7. 2006
    ..002). Regimens containing tenofovir provided effective control of HIV-1 infection, with stable CD4+ cell counts and continued suppression of plasma HIV-1 level following the treatment switch from stavudine...
  2. ncbi request reprint [Management of primary HIV-infection]
    C K Schewe
    Facharzt für Innere Medizin, Praxis St Georg, Hamburg
    MMW Fortschr Med 147:24-6. 2005
    ..Treatment should be carried out only in specialized infectious disease centers, most preferably within controlled clinical studies...
  3. ncbi request reprint Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment
    Oliver Schildgen
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitat Bonn, 53105 Bonn, Germany
    AIDS 18:2325-7. 2004
    ..In all cases adefovir was replaced by tenofovir, resulting in a significant drop in the viral load...